Get the best in custom peptide synthesis from Mimotopes.

With fully customisable sequences, including adjustments to peptide length, a wide range of additional modifications, and options for the N and C termini, we can start building the ideal peptides for your research today.

As experts in custom peptide manufacturing, we can modify peptides to suit any purpose. They can be supplied individually or as part of a PepSet™Peptide Library. Modifications can be made at the terminal ends of the peptide or internally.

Cyclisation

An unrestrained peptide may be unstable and unreliable. Cyclisation constrains conformations to add stability and increase peptide function.

Here are some examples of the cyclised peptides we provide.

Biotinylation

Biotinylated peptides make ideal candidates for screening purposes. Biotinylation allows a peptide to be immobilised or detected, which is especially useful in a PepSet™ Peptide Library.

Conjugation

Conjugation is a versatile custom peptide modification with applications in antibody generation, affinity purification, and cell transport, to name a few.


It’s possible to produce an immunogen by conjugating a peptide to a carrier protein, couple peptides to gel for affinity purification, or build heterodimers to cross the cell membrane.

and many more

The list of peptide modifications goes on!

  • Stable isotope labeled peptides
  • FRET peptides
  • fluorescently labelled peptides
  • Branched peptides
  • Phosphorylation
  • Glycosylation
  • Methylation
  • Acetylation
  • Pegylation
  • Amidation
  • Succinylation
  • Carbamylation
  • Fatty acid capping
  • Photocleavable linkers

Contact us today for a peptide quote! 

Australia

☎ +61 3 9565 1111

✉ australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

✉ useast@mimotopes.com
     uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com

UK / Europe / Africa / Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Go to article: Home | Catching the next Covid-19 variantGo to article: In this issueGo to article: ContentsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Mettler Toledo Company InsightGo to article: Data Integrity Solutions – METTLER TOLEDOGo to article: CommentGo to article: New coronavirus variant causing concern as cases spike in South AfricaGo to article: Teva and MedinCell looking to enter LAI schizophrenia marketGo to article: Lack of injectable anti-HIV therapies in the Japanese marketGo to article: Prevention of thrombosis in Covid-19 patientsGo to article: T2D therapy accepted into FDA Emerging Technology ProgramGo to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: ButterworthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: In DepthGo to article: Enter Amazon Pharmacy: the beginning of a great online pharmacy fight?Go to article: Covid-19 vaccines have made treating racism in medicine even more urgentGo to article: Could Covid-19 give pharma the chance for the ultimate image makeover?Go to article: Delivering a billion doses with the UK VMICGo to article: Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders GroupGo to article: Saxenda: profiling the first NHS weight loss drug for a decadeGo to article: How real-time genomic surveillance could spot new Covid-19 variantsGo to article: A new hope for slowing disability in MSGo to article: DatwylerGo to article: Datwyler Company Insight Go to article: ACG WorldwideGo to article: Gemini Data LoggersGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue